🇺🇸 FDA
Patent

US 7683173

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P1/00A61P1/06

Quick answer

US patent 7683173 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P1/00, A61P1/06, A61P1/12, A61P1/14